IL-13R alpha 1 Antibody (26) [PE]
Novus Biologicals, part of Bio-Techne | Catalog # NBP2-89716PE
Recombinant Monoclonal Antibody
Conjugate
Catalog #
Key Product Details
Species Reactivity
Validated:
Human
Applications
ELISA
Label
PE (Excitation = 488 nm, Emission = 575 nm)
Antibody Source
Recombinant Monoclonal Rabbit IgG Clone # 26
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Product Summary for IL-13R alpha 1 Antibody (26) [PE]
Immunogen
This antibody was obtained from a rabbit immunized with purified, recombinant Human IL-13R alpha 1 extracellular domain (Accession#: NP_001551.1; Met 1-Thr 343).
Specificity
No cross-reactivity in ELISA with:
Mouse IL13RA1 / CD213a1
Human IL13RA2 / IL13R
Human IL4R / IL4Ra / CD124
Human CSF2RB / CD131
Clonality
Monoclonal
Host
Rabbit
Isotype
IgG
Applications for IL-13R alpha 1 Antibody (26) [PE]
Application
Recommended Usage
ELISA
Optimal dilutions of this antibody should be experimentally determined.
Application Notes
Optimal dilution of this antibody should be experimentally determined.
Please Note: Optimal dilutions of this antibody should be experimentally determined.
Formulation, Preparation, and Storage
Purification
Protein A purified
Formulation
PBS
Preservative
0.05% Sodium Azide
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at 4C in the dark.
Background: IL-13 R alpha 1
Long Name
Interleukin 13 Receptor alpha 1
Alternate Names
CD213a1, IL-13Ra1, IL13R alpha 1, IL13RA1
Gene Symbol
IL13RA1
Additional IL-13 R alpha 1 Products
Product Documents for IL-13R alpha 1 Antibody (26) [PE]
Product Specific Notices for IL-13R alpha 1 Antibody (26) [PE]
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...